Predicting depression treatment response with brain imaging
Part of Mental health clinical trials.
This study uses a special brain-imaging headband to see if it can predict how well people with depression respond to a treatment called accelerated rTMS (a type of brain stimulation). It compares results with people who do not have depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have been diagnosed with major depression (for the treatment group) or have no recent depression (for the healthy control group)
- You agree to wear a headband that measures brain activity
- You have not had rTMS or SPRAVATO treatment in the past month
- You can speak and understand English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using brain imaging to guide the placement of transcranial magnetic stimulation (TMS) works better than the usual scalp-based targeting method for adults with treatment-resistant depression.
This study uses a special headband (TD-fNIRS) that measures brain activity to see if it can predict how well different depression treatments work. You would be starting a new treatment for depression (like ketamine, SPRAVATO, TMS, or antidepressants) and wear the headband before and during treatment.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
This trial tests an alternating combination of brain stimulation and brain imaging to see if it helps people with depression that hasn’t improved with usual treatments. The goal is to find a safer, more effective approach for people whose depression has been very difficult to treat.
This study looks at brain and heart-related measurements to predict who is most likely to improve with rTMS (repetitive transcranial magnetic stimulation) for depression. It may help future patients by identifying markers of treatment response.
This trial tests if brain scans or electrical signals can predict who will get better with TMS (transcranial magnetic stimulation) for depression. It is for people whose depression did not improve after trying two or more antidepressants.
Hear when a new fNIRS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.